Related Experiment Video
Updated: Jun 14, 2026
06:21
Multi-Gene Single Nucleotide Polymorphism Detection in Gastric Cancer Based on Ion Semiconductor Sequencing Platform
Published on: May 10, 2024
Testing gene-treatment interactions in pharmacogenetic studies.
1Department of Biostatistics and Bioinformatics, Duke University, Durham, North Carolina, USA.
Journal of Biopharmaceutical Statistics
|March 24, 2010
Summary
Identifying genes that influence drug response can personalize medicine and reduce adverse drug reactions. This study introduces a powerful new method for pharmacogenetic studies to find these crucial gene-treatment interactions.
Area of Science:
- Pharmacogenetics
- Genomics
- Drug Discovery
Background:
- Drug side effects are a major cause of morbidity and mortality.
- Personalized medicine requires understanding genetic influences on drug response.
- Current methods for identifying gene-treatment interactions have limitations.
Purpose of the Study:
- To develop a novel, powerful approach for testing gene-by-treatment interactions in case-control pharmacogenetic studies.
- To improve the identification of individuals who will benefit from specific drug therapies or are at higher risk of adverse events.
- To provide a flexible method applicable to both autosomal and X-linked genetic markers.
Main Methods:
- Utilized a retrospective statistical model for case-control pharmacogenetic analysis.
- Incorporated a Hardy-Weinberg equilibrium assumption in controls to enhance statistical power.
- Developed methods for both autosomal and X-linked genetic markers.
- Validated the approach through extensive computer simulations.
Main Results:
- The proposed method demonstrated comparable or superior statistical power to existing standard methods across various scenarios.
- The approach effectively identifies gene-treatment interactions without assuming the event of interest is rare.
- The methods are readily implementable in standard statistical software packages.
Conclusions:
- This novel approach offers a powerful and flexible tool for pharmacogenetic research.
- It facilitates the identification of genetic modulators of drug response, aiding in personalized medicine.
- The method's ease of implementation supports its widespread adoption in genetic and clinical research.
Related Concept Videos
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:27Pharmacogenetics of Drug Metabolism: Overview
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:29Pharmacogenetics and Pharmacogenomics: Overview
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
01:27Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...